Endorsed by the All Wales Medicines Strategy Group (AWMSG) and the Respiratory Health Implementation Group (RHIG), the All-Wales COPD Management and Prescribing guideline standardises the diagnostic process, and provides a consistent approach to care in Wales. The aim of this guideline is to optimise the greatest-value interventions for COPD which will help to reduce exacerbations and hospital admissions and save millions of pounds through correct inhaler prescribing. Key Recommendations:

• Identify objective evidence for a diagnosis of COPD
• Refer for smoking cessation therapy, flu vaccination, pulmonary rehabilitation, and oxygen assessment
• Categorise a patient according to their phenotype, to guide inhaled therapy